Comments for PRGO - Stockpickr! Your Source for Stock Ideas

Comments for PRGO

Added By	Comments	Type	Date Added
RhinoStocks	Increased dividend to $0.0625 from $0.055 for shareholders of record on November 5.	Love	November 03, 2009
barrons3	Buy -- Price 34.88 on Oct. 6 by Collins Stewart Reiterating Buy rating and 40 target ... following the company's approval for a store-brand version of Schering Plough's (SGP) Miralax [an anti-constipation treatment]. The approval is earlier than we had expected. Therefore, even though it is already incorporated in the company's F2010 financial guidance, there could be some upside to our forecasts. We estimate that store-brand Miralax will contribute at least 5 cents to our earnings estimate of $2.05 in F2010. To be conservative, we are making no changes to our guidance yet. Market cap: $3 billion.	Love	October 10, 2009
sarah z	From a recent Mad Money show:"I was surprised by the pullback, but they had a bad quarter. They should be doing well, but they aren't, so I'm a seller."	Love	February 06, 2009
High Dividends	10%	Love	November 09, 2008
Rcd284	seems to be steady	Love	October 22, 2008
stockerblog	PE of 23, a PEG of 0.87, and it pays a yield of 0.6%.	Love	October 15, 2008
barrons2	Just an awesome display. In fact, the only real stinker today -- besides Fannie Mae (FNM), which no one seems to care about -- was Perrigo (PRGO), and that's just because people had bid it up as a substitution play, a trade-down play, because it makes generic products.	Love	May 08, 2008
Tim Cole	Good long term investment	Love	March 12, 2008
sarah z	Generic drug and health care products maker Perrigo Co. said ts board authorized the repurchase of $150 million in common stock and declared a regular quarterly dividend of 5 cents per share. The company also announced that second-quarter earnings surged 63 percent on double-digit revenue growth, beating Wall Street estimates. The stock has a forward PE of 19.	Love	February 14, 2008
barrons2	Or there's Perrigo [PRGO], which takes drugs that go off patent and then makes a private-label product for drugstores to sell. It is getting terrific reception from drugstores. This company is just starting to accelerate with a number of new drugs like analgesics and vitamins and nutrition and gastrointestinal treatments. Its earnings in the last quarter were up 89%, largely because of good profit-margin improvements. The quarter before that earnings were up 26%, and that's coming off of a long, flat period. It should earn about $1.45 this year and probably $1.80 next year. The stock is around 31.	Love	February 02, 2008
barrons2	Outperform/Aggressive Risk -- Price 32.66 on Dec. 19 by Barrington Research Perrigo expects to begin shipping 20-milligram Omeprazole delayed-release tablets (store-brand equivalent to Prilosec OTC) during the calendar 1Q08 or during its fiscal 3Q. Initial annualized sales of the product are expected to be $150 million to $200 million ... We believe PRGO shares can trade at a price/earnings multiple of 25 times, due to PRGO's accelerating growth rate and robust pipeline. New target 42, from 35. Market-cap: $3.09 billion.	Love	December 22, 2007
mattycb	A current Gorilla Trade with excellent IBD ratings for attractiveness and accumulaition/distribution.	Love	November 13, 2007
High Dividends	11%	Love	November 05, 2007
supratrade	BUY	Love	August 09, 2007
blzj5595	thought it was underpriced	Love	August 06, 2007